Delivery Order SPE2DB22D3501-SPE2DB24FUE84
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,289.22, is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 4, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,218.48 for the pharmaceutical product Mounjaro 5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has a ceiling value of $1,507.93 and a completion date of August 24, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of the pharmaceutical product Mounjaro 10 mg/0.5 ml pen. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $7,591.97 and an ultimate completion date of September 8, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract, with a ceiling value of $3,029.35, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The award date is February 6, 2023, and the ultimate completion date is February 7, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,367.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC enables DLA to efficiently procure a comprehensive range of...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.8ML, a pharmaceutical product, with a ceiling value of $58,852.03 and a completion date of May 6, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,865.27 delivery order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a completion date of December 28, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,215.81 and a period of performance through February 27, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product. The $1,351.23 firm fixed price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 30, 2025 and was awarded on June 27, 2025. The contract is not set-aside and indicates open competition. As a large prime contractor, Amerisourcebergen Drug Corp...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUE84Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a ceiling value of $2,229.31 and an ultimate completion date of January 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/18/24 |